Skip to main content

Table 2 Clinical and imaging finding in RTRs and nRTRs

From: COVID-19 in renal transplant recipients and general population: a comparative study of clinical, laboratory, and radiological features, severity, and outcome

  Group P
Transplant Pts Non-transplant Pts
Count (n%) Count (n%)
Chills 11 (47.8) 13 (32.5) 0.228
NauseaVomiting 5 (21.7) 13 (32.5) 0.363
Diarrhea 5 (21.7) 12 (30.0) 0.477
Hemoptysis 1 (4.3) 0 (0.0) 0.189
Myalgia 6 (26.1) 15 (37.5) 0.355
headache 7 (30.4) 9 (22.5) 0.486
Anosmia 5 (21.7) 3 (9.4) 0.185
Fever 17 (73.9) 28 (70.0) 0.741
Cough 17 (73.9) 34 (85.0) 0.281
Dyspnea 16 (69.6) 36 (90.0) 0.045
Total GGO 22 (95.7) 38 (95.0) 0.701
Only GGO 2 (8.7) 6 (15) 0.381
Total consolidation 19 (82.6) 34 (85.0) 0.534
GGO + crazy paving 2 (8.7) 0 (0) 0.130
Only consolidation 1 (4.3) 2 (5) 0.701
GGO + consolidation 11 (47.8) 15 (37.5) 0.423
GGO + crazy paving + consolidation 7 (30.4) 17 (42.5) 0.342
Crazy paving 9 (39.1) 17 (42.5) 0.794
Multifocal bilateral 22 (95.7) 36 (97.3) 0.624
Multifocal unilateral 1 (4.3) 1 (2.7) 0.624
Unifocal 0 (0.0) 0 (0.0) -
Peripheral 16 (100.0) 36 (97.3) 0.698
Central 6 (37.5) 10 (27.0) 0.327
Reversedhalo 9 (39.1) 15 (44.1) 0.708
Linear opacities 9 (39.1) 17 (50.0) 0.419
Bronchiectasis 5 (21.7) 10 (29.4) 0.519
Pleural effusion 0 (0.0) 8 (23.5) 0.013
Pericardial effusion 2 (9.1) 4 (11.8) 0.560
Number of involved lobes 4.65 ± 0.70 (5.00 (5.00–5.00)) 4.32 ± 1.04 (5.00 (4.00–5.00)) 0.318
Total CT score 12.40 ± 5.87 (11.00 (8.00–18.00)) 11.59 ± 6.09 (10.50 (7.00–17.00)) 0.576